Sm-153 Quadramet Dose Form
Radiopharmaceutical Therapy Dose Documentation Form Sm-153 Samarium (Quadramet)
File: Sm-153_Quadramet_Dose_Form.pdfProtocols by System
Radium-223 May 2017
Radiopharmaceutical Therapy: Agent/Protocol-Specific Procedure Radium 223 dichloride (Xofigo®)
File: Radium-223_May_2017.pdfRadionuclide Therapy Process and Oversight March 2016
USE OF RADIONUCLIDE AGENTS IN THERAPEUTIC TREATMENT OF PATIENTS PROCEDURE
File: Radionuclide_Therapy_Process_and_Oversight_March_2016.pdfI-131 MIBG March 2017
Radiopharmaceutical Therapy: Agent/Protocol-Specific Procedure I-131 meta-iodobenzylguanidine (Iobenguane Sulfate) (MIBG)
File: I-131_mIBG_March_2017-1.pdfI-131 Therapy Dose Form April 2016
Radiopharmaceutical Therapy Dose Documentation FormI-131 Sodium Iodide
File: I-131_Therapy_Dose_Form_April-2016.pdfI-131 Sodium Iodide for Thyroid Cancer March 2017
I-131 Sodium Iodide for Thyroid Cancer Therapies Remnant Ablation and Cancer Metastases
File: I-131_Sodium_Iodide_for_Thyroid_Cancer_March_2017.pdfI-131 Sodium Iodide for Therapy Hyperthyroidism March 2017
Radiopharmaceutical Therapy: Agent/Protocol-Specific Procedure I-131 Sodium Iodide for Hyperthyroidism
File: I-131_Sodium_Iodide_for_Therapy_Hyperthyroidism_March_2017-1.pdfI-131 Sodium Iodide for Therapy Hyperthyroidism March 2017
Radiopharmaceutical Therapy: Agent/Protocol-Specific Procedure I-131 Sodium Iodide for Hyperthyroidism
File: I-131_Sodium_Iodide_for_Therapy_Hyperthyroidism_March_2017.pdfI-131 Sodium Iodide for Inpatient Use March 2017
I-131 sodium iodide is available as a stable aqueous solution or solid capsule form for oral administration. I-131 decays by beta emission (~90% of local irradiation) and associated gamma emission (~10% of local irradiation), with a physical half-life of 8.04 days.
File: I-131_mIBG_March_2017.pdfBone Scan Three Phase and Joint Scan 2017-03
Three Phase Bone Scan and Joint Scan
File: Bone-Scan-Three-Phase-and-Joint-Scan-2017-03.pdf